好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

The American Headache Society First Contact—Headache in Primary Care Program: Current Website Metrics and Direction for Future Initiatives
Headache
P11 - Poster Session 11 (5:30 PM-6:30 PM)
12-003

We examine the American Headache Society (AHS) First Contact Program website metrics to assess the program’s reach and provide direction for future initiatives. 

There is a shortage of headache specialists in the United States. The First Contact Program was created to help minimize the impact of the shortage by providing headache-related education to primary care providers. This is the first study to assess the reach of the program and critically examine how its resources can be used to aid those in underserved areas in order to better meet the needs of clinicians and patients.

We examined the First Contact Program website metrics from October 2020–June 2023 and program data from May 2020–October 2023.

The First Contact Program homepage was the second most visited page on the AHS website (>100,000 views). The most viewed Topic Pages were Diagnosing Migraine, Acute Treatment, Preventive Treatment, Lifestyle Changes, and Migraine in the Elderly (>30,000 views). Fifteen podcast episodes were created for the program (>3,500 plays). The most played episodes were Treating and Preventing Migraine, Headache Management over Telemedicine and Behavioral Treatment for Migraine. The First Contact Program held 93 events (68 grand rounds, 21 state-level, 4 national meetings) reaching >6,000 clinicians. The grand rounds spanned across 23 states and Washington D.C., while the state-level symposia were held across 12. Twenty-seven (30.33%) First Contact Program events occurred in states with few headache subspecialists or low headache subspecialist densities. Only five of the 17 patient guides are available in Spanish.

Now that educational content on headache medicine has been developed and delivered, future work may examine where the First Contact Program might focus initiatives based on “desert” areas for headache care and racial and ethnic disparities in headache care to further improve access to providers familiar with headache care.

Authors/Disclosures
Mia T. Minen, MD, FAAN (NYULMC Neurology)
PRESENTER
The institution of Dr. Minen has received research support from NIH. Dr. Minen has received intellectual property interests from a discovery or technology relating to health care. Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a First Contact-Primary Care Advisory Board Member with American Headache Society . Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PCORI grant on migraine evidence based map for stakeholders with ECRI .
Nina Y. Riggins, MD, FAAN (Headache Center of Excellence) Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Gerson Lehrman Group . Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. The institution of Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal Pharmaceuticals. Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NeurologyLive. The institution of Dr. Riggins has received research support from ElectroCore (GammaCore). The institution of Dr. Riggins has received research support from Miles for Migraine. The institution of Dr. Riggins has received research support from Eli Lilly. Dr. Riggins has received publishing royalties from a publication relating to health care. Dr. Riggins has received publishing royalties from a publication relating to health care. Dr. Riggins has received publishing royalties from a publication relating to health care. Dr. Riggins has a non-compensated relationship as a PI on research study with TheraSpecs that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a Advisory Board with NeurologyLive that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a Member of the Board with Miles for Migraine that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a PI in the study which used sphenocath device with Dolor Technologies that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a PI with Theranica that is relevant to AAN interests or activities.
Hayley Swiderski No disclosure on file
Erin Waire (NYU Langone Health) Erin Waire has nothing to disclose.
Adam S. Sprouse-Blum, MD, PhD (University of Vermont) Dr. Sprouse-Blum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Neuropharma. Dr. Sprouse-Blum has received personal compensation in the range of $5,000-$9,999 for serving as a CME presenter with American Headache Society.